83 FR 10 pgs. 2215-2216 - Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc.
Type: NOTICEVolume: 83Number: 10Pages: 2215 - 2216
Pages: 2215, 2216Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2018-00506 Filed 1-12-18; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc.
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 19, 2018.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division ("Assistant Administrator") pursuant to section 7 of 28 CFR 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on November 10, 2017, Johnson Matthey Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 19428 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Gamma Hydroxybutyric Acid | 2010 | I |
| Amphetamine | 1100 | II |
| Methylphenidate | 1724 | II |
| Codeine | 9050 | II |
| Oxycodone | 9143 | II |
| Diphenoxylate | 9170 | II |
| Hydrocodone | 9193 | II |
| Meperidine | 9230 | II |
| Methadone | 9250 | II |
| Methadone intermediate | 9254 | II |
| Morphine | 9300 | II |
| Thebaine | 9333 | II |
| Opium tincture | 9630 | II |
[top]
The company plans to manufacture the listed controlled substances in bulk for either internal use or for sale to its customers. Thebaine (9333) will be used to manufacture other controlled substances for sale in bulk to its customers.
Dated: January 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-00506 Filed 1-12-18; 8:45 am]
BILLING CODE 4410-09-P